Fiche société
Massachusetts General Hospital
Traitements, essais et publications liés.
Traitements46programmes
Essais27liés
Publications28liées
SourceDBlocale
Traitements
46| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive TherapyThis research study is evaluating the impact a collaborative palliative care and oncology team will have on end-of-life outcomes, quality of end-of-life care, and the quality of life, symptoms, and mood of patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) receiving non-intensive therapy | Cancer | NA | Traitement symptomatique | United States | À vérifier |
| Auricular transcutaneous electrical nerve stimulation deviceIn this research study we want to learn more about if transcutaneous electrical nerve stimulation (TENS), a safe electrical stimulation tool, can relieve Fibromyalgia pain. A total of 60 subjects with Fibromyalgia will be enrolled in this study at Massachusetts General Hospital, Charlestown Navy Yard campus. | SEP | Non applicable | Traitement symptomatique | United States | À vérifier |
| BaricitinibDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | Phase 1/2 | Immunomodulation + Traitement symptomatique | United States | À vérifier |
| DigoxinThe purpose of this study is to investigate the effects of multiple-dose administration of BIA 2-093 on the steady-state pharmacokinetics of digoxin in healthy subjects. | Épilepsie, Sclérose latérale amyotrophique | Phase 2 | À vérifier | United States | À vérifier |
| EplerenoneHIV has transitioned to a chronic disease in which well-treated persons remain at higher risk for heart disease when compared to the general population. Statin medications have been shown to reduce the number of events related to heart disease, but there are still individuals who will have complications from heart disease despite statin use. This study is being conducted to determine whether adding on another medication to statins called eplerenone, which has been shown to reduce inflammation in the heart vasculature among persons with HIV, can further decrease the risk of heart disease in HIV through its anti-inflammatory and blood pressure-lowering potential. | Maladie coronarienne | Phase 2/3 | Immunomodulation | United States | À vérifier |
| F-18 3F4APOur overall objective is to obtain an initial assessment of the potential value of using \[18F\]3F4AP for imaging demyelinating diseases such as multiple sclerosis: * Aim 1) Assess the safety of \[18F\]3F4AP in healthy volunteers and subjects with multiple sclerosis (MS). Hypothesis 1: Administration of \[18F\]3F4AP will result in no changes in vitals or other adverse events. * Aim 2) Assess the pharmacokinetics of a bolus infusion of \[18F\]3F4AP in humans including healthy volunteers and MS patients. Hypothesis 2: the pharmacokinetics of \[18F\]3F4AP at the whole brain level will be similar in controls and MS subjects. The kinetics in demyelinated lesions will be slower than in healthy control areas. * Aim 3) Assess the reproducibility of \[18F\]3F4AP in humans. Hypothesis 3: the test/retest variability of \[18F\]3F4AP within the same subject will be lower than 10%. * Aim 4) Correlate MR brain images with \[18F\]3F4AP PET brain images. Hypothesis 4A: all the lesions seen on the MRI will show increased signal (VT or SUV) on the PET images. Hypothesis 4B: some of the lesions on the MRI will show increased signal (VT or SUV) on the PET but not all. * Aim 5) Correlate \[18F\]3F4AP PET signal with neuropsychological testing in people with MS. Hypothesis 5: increased PET signal (VT or SUV) will correlate with impaired Single Digit Modality Test (SDMT) scores. * Aim 6) Correlate \[18F\]3F4AP PET signal with EDSS score in people with MS. Hypothesis 6: increased PET signal (VT or SUV) will correlate with higher EDSS scores. | SEP | Phase 1 | United States | À vérifier | |
| FDG-PET/fMRI/EEG imagingThis study aims to better understand how epilepsy alters brain function through neuroimaging of healthy people and people with epilepsy. The study investigates how changes in brain metabolism (sugar consumption, measured by positron emission tomography \[FDG-PET\], and blood flow, measured by functional magnetic resonance imaging \[fMRI\]) relate to abnormal interictal electrical activity associated with epilepsy (measured by electroencephalography \[EEG\]). The study will also compare how the three imaging modalities localize regions of abnormal function in the brain. | Épilepsie | À vérifier | À vérifier | United States | À vérifier |
| Hematopoietic Cell TransplantationThe primary objective is to assess the safety of the addition of venetoclax to reduced intensity conditioning for HLA-matched and haploidentical combined HSC and kidney transplantation as measured by stable full donor hematopoiesis and absence of CTCAE grade IV or V toxicity attributable to venetoclax. | Maladie rénale chronique | Phase 1 | À vérifier | United States | À vérifier |
| Hematopoietic Cell Transplantation Conditioning RegimenThe primary objective is to assess the safety of the addition of venetoclax to reduced intensity conditioning for HLA-matched and haploidentical combined HSC and kidney transplantation as measured by stable full donor hematopoiesis and absence of CTCAE grade IV or V toxicity attributable to venetoclax. | Maladie rénale chronique | Phase 1 | À vérifier | United States | À vérifier |
| Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis is that this patient-friendly physical therapist (PT)-guided exercise program associates with improved functional capacity and muscle composition in DM2 in this two-period two-sequence cross-over study. Thus, participant will be randomized to one of the three possible groups. Participants in GROUP A will perform exercise routine virtually under the direct supervision of a physical therapist once a week and another session on their own for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP B will perform exercise routine virtually under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP C will perform exercise routine on their own during the first 3 months, then they will perform exercise routine virtually under the direct supervision of a physical therapist. Each group will include around 8 participants. Duration of the study is 6 months. In addition to exercise sessions, participants will have evaluation of their strength, motor function and muscle composition at three time points: initiation, 3 months and completion of the study at 6 months. Muscle composition will be assessed by electrical impedance myography which is a portable, non-invasive, painless and non-radiation tool that applies a weak high multifrequency electrical current to the examined muscle and allows to obtain information about its composition. | Myopathies | NA | Traitement symptomatique | United States | À vérifier |
| Kidney TransplantThe primary objective is to assess the safety of the addition of venetoclax to reduced intensity conditioning for HLA-matched and haploidentical combined HSC and kidney transplantation as measured by stable full donor hematopoiesis and absence of CTCAE grade IV or V toxicity attributable to venetoclax. | Maladie rénale chronique | Phase 1 | À vérifier | United States | À vérifier |
| MCSP — Healey ALS MyMatch Common Screening ProtocolDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | À vérifier | À vérifier | À vérifier | |
| Optimal Stimulation Parameters to Disrupt Epileptiform ActivityOpen-loop electrical stimulation has been found to reduce spike activity and seizures, but determining the optimal parameters to achieve these effects requires a brute force trial-and-error approach that relies on subjective physician discretion. We compared the performance of stimulation parameters identified in rodent models to the recommended parameters for neuromodulation used in clinical practice. | Épilepsie | Non applicable | À vérifier | United States | À vérifier |
| Proximal Splenic Artery EmbolizationThe purpose of this study is to learn whether a procedure called Proximal Splenic Artery Embolization (PSAE) can lower the need for repeat fluid drainage in adults with cirrhosis and a buildup of fluid in the abdomen (ascites) that is no longer controlled by water pills and diet. Participants in this study have already been told that a standard procedure called Trans jugular Intrahepatic Portosystemic Shunt (TIPS) is not a safe option for them. The main objectives this study aims to answer are: * Does PSAE lower how often participants need paracentesis, the procedure used to drain fluid from the abdomen? * Does PSAE lower the total amount of fluid drained each month? * Does PSAE change the pressure inside the liver's veins and the blood flow in the liver and spleen? * Does PSAE improve day-to-day symptoms, quality of life, strength, and the ability to do usual activities? * What side effects or complications happen with PSAE in this group of people? Participants will: * Undergo one PSAE procedure, during which small coils and/or plugs are placed in the artery that supplies the spleen to slow its blood flow * Have a pressure measurement taken in the liver's veins right before and right after the procedure, with a repeat measurement at 1 month * Attend follow-up visits at 1, 3, and 6 months that include blood tests, ultrasounds, symptoms and quality-of-life questionnaires, and a review of any paracentesis sessions since the last visit * Have a Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) and an ultrasound of the liver and spleen blood vessels at the start of the study and again at 6 months | Hypertension | Non applicable | Traitement symptomatique | United States | À vérifier |
| Relative Blood Volume Monitoring (RBVM)The investigators are examining how adding relative blood volume monitoring (RBVM) to the best clinical practice affects outcomes (length of stay and rehospitalization) among dialysis patients hospitalized for or with volume overload. | Maladie rénale chronique | À vérifier | À vérifier | United States | À vérifier |
| Relaxation Response Training to Treat HypertensionInterventions such as Relaxation Response appear to have widespread effects on physiology. Endothelial function, changes in genomic expression, several biomarkers have been associated with chronic stress and cardiovascular dysfunction, and there is some suggestion that elicitation of the Relaxation Response may lead to improvement in-or normalization of-these factors. By studying the impact of the Relaxation Response on endothelial function, genomic expression and biomarkers among subjects with hypertension, it may be possible to better understand the biologic underpinnings of Relaxation Response-type interventions. Furthermore, with a greater understanding of the physiologic mechanisms by which the Relaxation Response works, it may be possible to better target other symptoms and conditions that can be effectively treated by such an intervention. | Hypertension | NA | Traitement symptomatique | United States | À vérifier |
| Sleep Spindles and Memory in Rolandic EpilepsyThe investigators are recruiting children with Rolandic epilepsy and children without epilepsy (aged 4 years old and above) for a non-invasive brain imaging study using Magnetic Resonance Imaging (MRI), Magnetoencephalography/Electroencephalography (MEG/EEG), and experimental tasks. The investigators hope to determine the brain circuits and brain rhythms affected in these children and ultimately identify new treatment options for childhood epilepsy patients. | Épilepsie | Non applicable | À vérifier | United States | À vérifier |
| Supporting Our Caregivers In ADRD Learning (SOCIAL)Building on limitations of prior research, the investigators developed the Mindful and Self-Compassionate Care Program (MASC) to help caregivers of persons with Alzheimer Disease and Related Dementias (ADRD) manage stress associated with the general caregiver experience including stress stemming from managing challenging patient behaviors. MASC teaches: (1) mindfulness skills; (2) compassion and self-compassion skills; and (3) behavioral management skills. MASC also provides psychoeducation and group-based training and skill practice to facilitate skill uptake and integration within the caregiver experience and tasks. The main aim is to: Demonstrate feasibility, acceptability, credibility, fidelity, preliminary efficacy and evidence for proposed mechanism of MASC through a pilot randomized controlled trial. Relevant stakeholders (caregivers of persons with ADRD) will participate in the intervention. | Alzheimer | Non applicable | À vérifier | United States | À vérifier |
| taVNSThis randomized controlled trial aimed to compare the effects of unilateral (left-sided) and bilateral transcutaneous auricular vagus nerve stimulation (taVNS) combined with a home exercise program on clinical outcomes, autonomic nervous system function, and exercise performance in individuals with fibromyalgia syndrome (FMS). Participants diagnosed with fibromyalgia were randomly assigned to one of three groups: unilateral taVNS, bilateral taVNS, or a home exercise program. The intervention period lasted two weeks and included ten treatment sessions. Clinical outcomes were assessed using validated scales including the Fibromyalgia Impact Questionnaire (FIQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Autonomic function was evaluated using heart rate variability (HRV) parameters, and exercise performance was assessed based on repetition capacity. The study aimed to determine whether bilateral stimulation provides additional benefits compared to unilateral stimulation and exercise alone. The findings may contribute to understanding the role of neuromodulation strategies in improving autonomic regulation, symptom severity, and functional performance in individuals with fibromyalgia. | Parkinson, SEP | Non applicable | Traitement symptomatique | United States | À vérifier |
| transcutaneous vagus nerve stimulationAttaining goals or rewards commonly entails response costs. In light of cost and benefits, how do participants decide what effort should be put in to give it a shot? Figuratively, you may "go with your gut", but the literal contribution of the gut-brain axis in allocating effort is poorly understood to date. Here, the investigators propose to investigate non-invasive transcutaneous vagal nerve stimulation (tVNS) as a potential modulator of energy metabolism and response vigor. Since the neural mechanisms causing the diverse cognitive and behavioral effects of the stimulation remain largely elusive, the investigators will use computational modeling of instrumental behavior and determine the primary metabolic effects of the stimulation. The investigators hypothesize that tVNS will lead to activation of afferent targets in the brain. In turn, the elicited brain activation is expected to mediate the cognitive effects of the stimulation. This may affect both sides of the utility equation because anti-depressive effects may correspond to boosting the benefit of effort whereas anti-nociceptive effects may reduce perceived costs of effort. Collectively, dissecting the cognitive effects of non-invasive tVNS in healthy individuals may facilitate the more widespread use as a treatment in mental disorders that are characterized by metabolic alterations such as depression. | Myopathies, Parkinson, SEP | Non applicable | À vérifier | United States | À vérifier |
| WALLe — The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive PerformanceIn this research study the investigators want to find out if a non-invasive electrical brain stimulation method called RAVANS (also called tVNS) can have a beneficial effect on cognition in older individuals. The investigators also want to understand whether certain individual factors contribute to the effect of RAVANS on cognition. RAVANS is only used in research studies. | Alzheimer | Non applicable | À vérifier | United States | À vérifier |
| Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis is that this patient-friendly physical therapist (PT)-guided exercise program associates with improved functional capacity and muscle composition in DM2 in this two-period two-sequence cross-over study. Thus, participant will be randomized to one of the three possible groups. Participants in GROUP A will perform exercise routine virtually under the direct supervision of a physical therapist once a week and another session on their own for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP B will perform exercise routine virtually under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP C will perform exercise routine on their own during the first 3 months, then they will perform exercise routine virtually under the direct supervision of a physical therapist. Each group will include around 8 participants. Duration of the study is 6 months. In addition to exercise sessions, participants will have evaluation of their strength, motor function and muscle composition at three time points: initiation, 3 months and completion of the study at 6 months. Muscle composition will be assessed by electrical impedance myography which is a portable, non-invasive, painless and non-radiation tool that applies a weak high multifrequency electrical current to the examined muscle and allows to obtain information about its composition. | Myopathies | NA | Traitement symptomatique | United States | À vérifier |
| A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive TherapyThis research study is evaluating the impact a collaborative palliative care and oncology team will have on end-of-life outcomes, quality of end-of-life care, and the quality of life, symptoms, and mood of patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) receiving non-intensive therapy | Cancer | NA | Traitement symptomatique | United States | À vérifier |
| Relaxation Response Training to Treat HypertensionInterventions such as Relaxation Response appear to have widespread effects on physiology. Endothelial function, changes in genomic expression, several biomarkers have been associated with chronic stress and cardiovascular dysfunction, and there is some suggestion that elicitation of the Relaxation Response may lead to improvement in-or normalization of-these factors. By studying the impact of the Relaxation Response on endothelial function, genomic expression and biomarkers among subjects with hypertension, it may be possible to better understand the biologic underpinnings of Relaxation Response-type interventions. Furthermore, with a greater understanding of the physiologic mechanisms by which the Relaxation Response works, it may be possible to better target other symptoms and conditions that can be effectively treated by such an intervention. | Hypertension | NA | Traitement symptomatique | United States | À vérifier |
| transcutaneous vagus nerve stimulationAttaining goals or rewards commonly entails response costs. In light of cost and benefits, how do participants decide what effort should be put in to give it a shot? Figuratively, you may "go with your gut", but the literal contribution of the gut-brain axis in allocating effort is poorly understood to date. Here, the investigators propose to investigate non-invasive transcutaneous vagal nerve stimulation (tVNS) as a potential modulator of energy metabolism and response vigor. Since the neural mechanisms causing the diverse cognitive and behavioral effects of the stimulation remain largely elusive, the investigators will use computational modeling of instrumental behavior and determine the primary metabolic effects of the stimulation. The investigators hypothesize that tVNS will lead to activation of afferent targets in the brain. In turn, the elicited brain activation is expected to mediate the cognitive effects of the stimulation. This may affect both sides of the utility equation because anti-depressive effects may correspond to boosting the benefit of effort whereas anti-nociceptive effects may reduce perceived costs of effort. Collectively, dissecting the cognitive effects of non-invasive tVNS in healthy individuals may facilitate the more widespread use as a treatment in mental disorders that are characterized by metabolic alterations such as depression. | SEP | Non applicable | À vérifier | Germany | À vérifier |
| Sleep Spindles and Memory in Rolandic EpilepsyThe investigators are recruiting children with Rolandic epilepsy and children without epilepsy (aged 4 years old and above) for a non-invasive brain imaging study using Magnetic Resonance Imaging (MRI), Magnetoencephalography/Electroencephalography (MEG/EEG), and experimental tasks. The investigators hope to determine the brain circuits and brain rhythms affected in these children and ultimately identify new treatment options for childhood epilepsy patients. | Épilepsie | Non applicable | À vérifier | United States | À vérifier |
| DigoxinThe purpose of this study is to investigate the effects of multiple-dose administration of BIA 2-093 on the steady-state pharmacokinetics of digoxin in healthy subjects. | Sclérose latérale amyotrophique | Phase 2 | À vérifier | United States | À vérifier |
| MCSP — Healey ALS MyMatch Common Screening ProtocolDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | À vérifier | À vérifier | À vérifier | |
| Proximal Splenic Artery EmbolizationThe purpose of this study is to learn whether a procedure called Proximal Splenic Artery Embolization (PSAE) can lower the need for repeat fluid drainage in adults with cirrhosis and a buildup of fluid in the abdomen (ascites) that is no longer controlled by water pills and diet. Participants in this study have already been told that a standard procedure called Trans jugular Intrahepatic Portosystemic Shunt (TIPS) is not a safe option for them. The main objectives this study aims to answer are: * Does PSAE lower how often participants need paracentesis, the procedure used to drain fluid from the abdomen? * Does PSAE lower the total amount of fluid drained each month? * Does PSAE change the pressure inside the liver's veins and the blood flow in the liver and spleen? * Does PSAE improve day-to-day symptoms, quality of life, strength, and the ability to do usual activities? * What side effects or complications happen with PSAE in this group of people? Participants will: * Undergo one PSAE procedure, during which small coils and/or plugs are placed in the artery that supplies the spleen to slow its blood flow * Have a pressure measurement taken in the liver's veins right before and right after the procedure, with a repeat measurement at 1 month * Attend follow-up visits at 1, 3, and 6 months that include blood tests, ultrasounds, symptoms and quality-of-life questionnaires, and a review of any paracentesis sessions since the last visit * Have a Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) and an ultrasound of the liver and spleen blood vessels at the start of the study and again at 6 months | Hypertension | Non applicable | Traitement symptomatique | United States | À vérifier |
| BaricitinibDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | Phase 1/2 | Immunomodulation + Traitement symptomatique | United States | À vérifier |
| transcutaneous vagus nerve stimulationAttaining goals or rewards commonly entails response costs. In light of cost and benefits, how do participants decide what effort should be put in to give it a shot? Figuratively, you may "go with your gut", but the literal contribution of the gut-brain axis in allocating effort is poorly understood to date. Here, the investigators propose to investigate non-invasive transcutaneous vagal nerve stimulation (tVNS) as a potential modulator of energy metabolism and response vigor. Since the neural mechanisms causing the diverse cognitive and behavioral effects of the stimulation remain largely elusive, the investigators will use computational modeling of instrumental behavior and determine the primary metabolic effects of the stimulation. The investigators hypothesize that tVNS will lead to activation of afferent targets in the brain. In turn, the elicited brain activation is expected to mediate the cognitive effects of the stimulation. This may affect both sides of the utility equation because anti-depressive effects may correspond to boosting the benefit of effort whereas anti-nociceptive effects may reduce perceived costs of effort. Collectively, dissecting the cognitive effects of non-invasive tVNS in healthy individuals may facilitate the more widespread use as a treatment in mental disorders that are characterized by metabolic alterations such as depression. | SEP | Non applicable | Immunomodulation | Belgium | À vérifier |
| transcutaneous vagus nerve stimulationAttaining goals or rewards commonly entails response costs. In light of cost and benefits, how do participants decide what effort should be put in to give it a shot? Figuratively, you may "go with your gut", but the literal contribution of the gut-brain axis in allocating effort is poorly understood to date. Here, the investigators propose to investigate non-invasive transcutaneous vagal nerve stimulation (tVNS) as a potential modulator of energy metabolism and response vigor. Since the neural mechanisms causing the diverse cognitive and behavioral effects of the stimulation remain largely elusive, the investigators will use computational modeling of instrumental behavior and determine the primary metabolic effects of the stimulation. The investigators hypothesize that tVNS will lead to activation of afferent targets in the brain. In turn, the elicited brain activation is expected to mediate the cognitive effects of the stimulation. This may affect both sides of the utility equation because anti-depressive effects may correspond to boosting the benefit of effort whereas anti-nociceptive effects may reduce perceived costs of effort. Collectively, dissecting the cognitive effects of non-invasive tVNS in healthy individuals may facilitate the more widespread use as a treatment in mental disorders that are characterized by metabolic alterations such as depression. | SEP | Non applicable | À vérifier | Canada | À vérifier |
| Supporting Our Caregivers In ADRD Learning (SOCIAL)Building on limitations of prior research, the investigators developed the Mindful and Self-Compassionate Care Program (MASC) to help caregivers of persons with Alzheimer Disease and Related Dementias (ADRD) manage stress associated with the general caregiver experience including stress stemming from managing challenging patient behaviors. MASC teaches: (1) mindfulness skills; (2) compassion and self-compassion skills; and (3) behavioral management skills. MASC also provides psychoeducation and group-based training and skill practice to facilitate skill uptake and integration within the caregiver experience and tasks. The main aim is to: Demonstrate feasibility, acceptability, credibility, fidelity, preliminary efficacy and evidence for proposed mechanism of MASC through a pilot randomized controlled trial. Relevant stakeholders (caregivers of persons with ADRD) will participate in the intervention. | Alzheimer | Non applicable | À vérifier | United States | À vérifier |
| Optimal Stimulation Parameters to Disrupt Epileptiform ActivityOpen-loop electrical stimulation has been found to reduce spike activity and seizures, but determining the optimal parameters to achieve these effects requires a brute force trial-and-error approach that relies on subjective physician discretion. We compared the performance of stimulation parameters identified in rodent models to the recommended parameters for neuromodulation used in clinical practice. | Épilepsie | Non applicable | À vérifier | United States | À vérifier |
| WALLe — The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive PerformanceIn this research study the investigators want to find out if a non-invasive electrical brain stimulation method called RAVANS (also called tVNS) can have a beneficial effect on cognition in older individuals. The investigators also want to understand whether certain individual factors contribute to the effect of RAVANS on cognition. RAVANS is only used in research studies. | Alzheimer | Non applicable | À vérifier | United States | À vérifier |
| transcutaneous vagus nerve stimulationAttaining goals or rewards commonly entails response costs. In light of cost and benefits, how do participants decide what effort should be put in to give it a shot? Figuratively, you may "go with your gut", but the literal contribution of the gut-brain axis in allocating effort is poorly understood to date. Here, the investigators propose to investigate non-invasive transcutaneous vagal nerve stimulation (tVNS) as a potential modulator of energy metabolism and response vigor. Since the neural mechanisms causing the diverse cognitive and behavioral effects of the stimulation remain largely elusive, the investigators will use computational modeling of instrumental behavior and determine the primary metabolic effects of the stimulation. The investigators hypothesize that tVNS will lead to activation of afferent targets in the brain. In turn, the elicited brain activation is expected to mediate the cognitive effects of the stimulation. This may affect both sides of the utility equation because anti-depressive effects may correspond to boosting the benefit of effort whereas anti-nociceptive effects may reduce perceived costs of effort. Collectively, dissecting the cognitive effects of non-invasive tVNS in healthy individuals may facilitate the more widespread use as a treatment in mental disorders that are characterized by metabolic alterations such as depression. | Myopathies | Non applicable | À vérifier | United States | À vérifier |
| taVNSThis randomized controlled trial aimed to compare the effects of unilateral (left-sided) and bilateral transcutaneous auricular vagus nerve stimulation (taVNS) combined with a home exercise program on clinical outcomes, autonomic nervous system function, and exercise performance in individuals with fibromyalgia syndrome (FMS). Participants diagnosed with fibromyalgia were randomly assigned to one of three groups: unilateral taVNS, bilateral taVNS, or a home exercise program. The intervention period lasted two weeks and included ten treatment sessions. Clinical outcomes were assessed using validated scales including the Fibromyalgia Impact Questionnaire (FIQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Autonomic function was evaluated using heart rate variability (HRV) parameters, and exercise performance was assessed based on repetition capacity. The study aimed to determine whether bilateral stimulation provides additional benefits compared to unilateral stimulation and exercise alone. The findings may contribute to understanding the role of neuromodulation strategies in improving autonomic regulation, symptom severity, and functional performance in individuals with fibromyalgia. | SEP | Non applicable | Traitement symptomatique | Turkey (Türkiye) | À vérifier |
| transcutaneous vagus nerve stimulationAttaining goals or rewards commonly entails response costs. In light of cost and benefits, how do participants decide what effort should be put in to give it a shot? Figuratively, you may "go with your gut", but the literal contribution of the gut-brain axis in allocating effort is poorly understood to date. Here, the investigators propose to investigate non-invasive transcutaneous vagal nerve stimulation (tVNS) as a potential modulator of energy metabolism and response vigor. Since the neural mechanisms causing the diverse cognitive and behavioral effects of the stimulation remain largely elusive, the investigators will use computational modeling of instrumental behavior and determine the primary metabolic effects of the stimulation. The investigators hypothesize that tVNS will lead to activation of afferent targets in the brain. In turn, the elicited brain activation is expected to mediate the cognitive effects of the stimulation. This may affect both sides of the utility equation because anti-depressive effects may correspond to boosting the benefit of effort whereas anti-nociceptive effects may reduce perceived costs of effort. Collectively, dissecting the cognitive effects of non-invasive tVNS in healthy individuals may facilitate the more widespread use as a treatment in mental disorders that are characterized by metabolic alterations such as depression. | Parkinson | Non applicable | Traitement symptomatique | À vérifier | |
| F-18 3F4APOur overall objective is to obtain an initial assessment of the potential value of using \[18F\]3F4AP for imaging demyelinating diseases such as multiple sclerosis: * Aim 1) Assess the safety of \[18F\]3F4AP in healthy volunteers and subjects with multiple sclerosis (MS). Hypothesis 1: Administration of \[18F\]3F4AP will result in no changes in vitals or other adverse events. * Aim 2) Assess the pharmacokinetics of a bolus infusion of \[18F\]3F4AP in humans including healthy volunteers and MS patients. Hypothesis 2: the pharmacokinetics of \[18F\]3F4AP at the whole brain level will be similar in controls and MS subjects. The kinetics in demyelinated lesions will be slower than in healthy control areas. * Aim 3) Assess the reproducibility of \[18F\]3F4AP in humans. Hypothesis 3: the test/retest variability of \[18F\]3F4AP within the same subject will be lower than 10%. * Aim 4) Correlate MR brain images with \[18F\]3F4AP PET brain images. Hypothesis 4A: all the lesions seen on the MRI will show increased signal (VT or SUV) on the PET images. Hypothesis 4B: some of the lesions on the MRI will show increased signal (VT or SUV) on the PET but not all. * Aim 5) Correlate \[18F\]3F4AP PET signal with neuropsychological testing in people with MS. Hypothesis 5: increased PET signal (VT or SUV) will correlate with impaired Single Digit Modality Test (SDMT) scores. * Aim 6) Correlate \[18F\]3F4AP PET signal with EDSS score in people with MS. Hypothesis 6: increased PET signal (VT or SUV) will correlate with higher EDSS scores. | SEP | Phase 1 | United States | À vérifier | |
| taVNSThis randomized controlled trial aimed to compare the effects of unilateral (left-sided) and bilateral transcutaneous auricular vagus nerve stimulation (taVNS) combined with a home exercise program on clinical outcomes, autonomic nervous system function, and exercise performance in individuals with fibromyalgia syndrome (FMS). Participants diagnosed with fibromyalgia were randomly assigned to one of three groups: unilateral taVNS, bilateral taVNS, or a home exercise program. The intervention period lasted two weeks and included ten treatment sessions. Clinical outcomes were assessed using validated scales including the Fibromyalgia Impact Questionnaire (FIQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Autonomic function was evaluated using heart rate variability (HRV) parameters, and exercise performance was assessed based on repetition capacity. The study aimed to determine whether bilateral stimulation provides additional benefits compared to unilateral stimulation and exercise alone. The findings may contribute to understanding the role of neuromodulation strategies in improving autonomic regulation, symptom severity, and functional performance in individuals with fibromyalgia. | Parkinson | Non applicable | Traitement symptomatique | À vérifier | |
| Relative Blood Volume Monitoring (RBVM)The investigators are examining how adding relative blood volume monitoring (RBVM) to the best clinical practice affects outcomes (length of stay and rehospitalization) among dialysis patients hospitalized for or with volume overload. | Maladie rénale chronique | À vérifier | À vérifier | United States | À vérifier |
| EplerenoneHIV has transitioned to a chronic disease in which well-treated persons remain at higher risk for heart disease when compared to the general population. Statin medications have been shown to reduce the number of events related to heart disease, but there are still individuals who will have complications from heart disease despite statin use. This study is being conducted to determine whether adding on another medication to statins called eplerenone, which has been shown to reduce inflammation in the heart vasculature among persons with HIV, can further decrease the risk of heart disease in HIV through its anti-inflammatory and blood pressure-lowering potential. | Maladie coronarienne | Phase 2/3 | Immunomodulation | United States | À vérifier |
| taVNSThis randomized controlled trial aimed to compare the effects of unilateral (left-sided) and bilateral transcutaneous auricular vagus nerve stimulation (taVNS) combined with a home exercise program on clinical outcomes, autonomic nervous system function, and exercise performance in individuals with fibromyalgia syndrome (FMS). Participants diagnosed with fibromyalgia were randomly assigned to one of three groups: unilateral taVNS, bilateral taVNS, or a home exercise program. The intervention period lasted two weeks and included ten treatment sessions. Clinical outcomes were assessed using validated scales including the Fibromyalgia Impact Questionnaire (FIQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Autonomic function was evaluated using heart rate variability (HRV) parameters, and exercise performance was assessed based on repetition capacity. The study aimed to determine whether bilateral stimulation provides additional benefits compared to unilateral stimulation and exercise alone. The findings may contribute to understanding the role of neuromodulation strategies in improving autonomic regulation, symptom severity, and functional performance in individuals with fibromyalgia. | SEP | Non applicable | Traitement symptomatique | United States | À vérifier |
| Auricular transcutaneous electrical nerve stimulation deviceIn this research study we want to learn more about if transcutaneous electrical nerve stimulation (TENS), a safe electrical stimulation tool, can relieve Fibromyalgia pain. A total of 60 subjects with Fibromyalgia will be enrolled in this study at Massachusetts General Hospital, Charlestown Navy Yard campus. | SEP | Non applicable | Traitement symptomatique | United States | À vérifier |
| FDG-PET/fMRI/EEG imagingThis study aims to better understand how epilepsy alters brain function through neuroimaging of healthy people and people with epilepsy. The study investigates how changes in brain metabolism (sugar consumption, measured by positron emission tomography \[FDG-PET\], and blood flow, measured by functional magnetic resonance imaging \[fMRI\]) relate to abnormal interictal electrical activity associated with epilepsy (measured by electroencephalography \[EEG\]). The study will also compare how the three imaging modalities localize regions of abnormal function in the brain. | Épilepsie | À vérifier | À vérifier | United States | À vérifier |
| transcutaneous vagus nerve stimulationAttaining goals or rewards commonly entails response costs. In light of cost and benefits, how do participants decide what effort should be put in to give it a shot? Figuratively, you may "go with your gut", but the literal contribution of the gut-brain axis in allocating effort is poorly understood to date. Here, the investigators propose to investigate non-invasive transcutaneous vagal nerve stimulation (tVNS) as a potential modulator of energy metabolism and response vigor. Since the neural mechanisms causing the diverse cognitive and behavioral effects of the stimulation remain largely elusive, the investigators will use computational modeling of instrumental behavior and determine the primary metabolic effects of the stimulation. The investigators hypothesize that tVNS will lead to activation of afferent targets in the brain. In turn, the elicited brain activation is expected to mediate the cognitive effects of the stimulation. This may affect both sides of the utility equation because anti-depressive effects may correspond to boosting the benefit of effort whereas anti-nociceptive effects may reduce perceived costs of effort. Collectively, dissecting the cognitive effects of non-invasive tVNS in healthy individuals may facilitate the more widespread use as a treatment in mental disorders that are characterized by metabolic alterations such as depression. | Myopathies | Non applicable | À vérifier | United States | À vérifier |
Essais cliniques
27| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| transcutaneous vagus nerve stimulation | Myopathies | Non applicable | NCT07904351 | R61VNS — Toward Biomarker-Guided Fibromyalgia Treatment With Non-Invasive Vagus Nerve Stimulation | NOT_YET_RECRUITING |
| FDG-PET/fMRI/EEG imaging | Épilepsie | À vérifier | NCT06974305 | PET/MRI/EEG Imaging Study in Epilepsy | RECRUITING |
| Auricular transcutaneous electrical nerve stimulation device | SEP | Non applicable | NCT04777500 | taVNS Treatment for Fibromyalgia | NOT_YET_RECRUITING |
| taVNS | SEP | Non applicable | NCT03603730 | Vagal Nerve Stimulation for Interoception Modulation | COMPLETED |
| Eplerenone | Maladie coronarienne | Phase 2/3 | NCT07892664 | SUNRISE HIV — Reducing Arterial Inflammation Using Eplerenone and Statins in HIV | NOT_YET_RECRUITING |
| Relative Blood Volume Monitoring (RBVM) | Maladie rénale chronique | À vérifier | NCT07866872 | Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission | ENROLLING_BY_INVITATION |
| Venetoclax | Maladie rénale chronique | Phase 1 | NCT07358195 | Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation | RECRUITING |
| taVNS | Parkinson | Non applicable | NCT07673146 | Probing Gut-Brain Communication in Parkinson's Disease | NOT_YET_RECRUITING |
| F-18 3F4AP | SEP | Phase 1 | NCT04699747 | Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects | RECRUITING |
| transcutaneous vagus nerve stimulation | Parkinson | Non applicable | NCT07839481 | tcVNS-PD — Effects of Transcutaneous Cervical Vagus Nerve Stimulation on Non-motor Symptoms in Parkinson's Disease | NOT_YET_RECRUITING |
| taVNS | SEP | Non applicable | NCT07577102 | taVNS-FMS — Unilateral and Bilateral taVNS in Fibromyalgia | COMPLETED |
| Theophylline | SEP | Phase 4 | NCT03718403 | Effect of Theophylline in Pseudohypoparathyroidism | RECRUITING |
| transcutaneous vagus nerve stimulation | Myopathies | Non applicable | NCT06009159 | Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients | RECRUITING |
| WALLe — The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive Performance | Alzheimer | Non applicable | NCT04908358 | WALLe — The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive Performance | COMPLETED |
| Optimal Stimulation Parameters to Disrupt Epileptiform Activity | Épilepsie | Non applicable | NCT06141668 | Optimal Stimulation Parameters to Disrupt Epileptiform Activity | COMPLETED |
| Supporting Our Caregivers In ADRD Learning (SOCIAL) | Alzheimer | Non applicable | NCT06276023 | Supporting Our Caregivers In ADRD Learning (SOCIAL) | COMPLETED |
| transcutaneous vagus nerve stimulation | SEP | Non applicable | NCT03440255 | Transcutaneous Vagus Nerve Stimulation in Private Healthcare Center | COMPLETED |
| transcutaneous vagus nerve stimulation | SEP | Non applicable | NCT03553485 | Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLC | UNKNOWN |
| Baricitinib | Sclérose latérale amyotrophique | Phase 1/2 | NCT05189106 | Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial | COMPLETED |
| Proximal Splenic Artery Embolization | Hypertension | Non applicable | NCT07755059 | Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis | NOT_YET_RECRUITING |
| MCSP — Healey ALS MyMatch Common Screening Protocol | Sclérose latérale amyotrophique | À vérifier | NCT07400393 | MCSP — Healey ALS MyMatch Common Screening Protocol | NOT_YET_RECRUITING |
| Digoxin | Sclérose latérale amyotrophique | Phase 2 | NCT07047209 | ACACIA — Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS) | COMPLETED |
| Sleep Spindles and Memory in Rolandic Epilepsy | Épilepsie | Non applicable | NCT04569708 | Sleep Spindles and Memory in Rolandic Epilepsy | WITHDRAWN |
| transcutaneous vagus nerve stimulation | SEP | Non applicable | NCT05120336 | tVNS Effects on Motivation in Depression | COMPLETED |
| Relaxation Response Training to Treat Hypertension | Hypertension | NA | NCT01263743 | Relaxation Response Training to Treat Hypertension | COMPLETED |
| A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy | Cancer | NA | NCT03310918 | A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy | ACTIVE_NOT_RECRUITING |
| Investigating Exercise in Myotonic Dystrophy Type 2 (DM2) | Myopathies | NA | NCT06716931 | Investigating Exercise in Myotonic Dystrophy Type 2 (DM2) | RECRUITING |
Publications
28| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Sleep Spindles and Memory in Rolandic Epilepsy | Association of Sleep Spindle Rate With Memory Consolidation in Children With Rolandic Epilepsy. | Neurology | ||
| Sleep Spindles and Memory in Rolandic Epilepsy | Changes in slow oscillations and sleep spindles by auditory stimulation positively correlate with memory consolidation in children with epilepsy and controls. | bioRxiv : the preprint server for biology | ||
| Sleep Spindles and Memory in Rolandic Epilepsy | Auditory-evoked changes in slow oscillations and spindles correlate with memory consolidation in children with epilepsy and controls. | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology | ||
| Baricitinib | Next-generation Janus kinase inhibitors: Integrating synthetic innovation, structural biology, and computational design for precision drug discovery. | Pharmaceutical science advances | ||
| Baricitinib | Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study. | The Journal of dermatological treatment | ||
| Baricitinib | Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment. | The Journal of dermatological treatment | ||
| Digoxin | Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. | Biochemical and biophysical research communications | ||
| Digoxin | Evolving paradigms in cardiovascular pharmacology: advances and clinical significance. | Current problems in cardiology | ||
| Proximal Splenic Artery Embolization | Splenic Artery Embolization for Refractory Ascites Following Hepatectomy for Hepatocellular Carcinoma. | Indian journal of surgical oncology | ||
| Proximal Splenic Artery Embolization | Comparative Analysis of the LOBO Device and Coils for Proximal Splenic Artery Embolization: A Multi-Institutional Retrospective Study. | Cardiovascular and interventional radiology | ||
| Proximal Splenic Artery Embolization | Incidental intrahepatic cholangiocarcinoma detected in the explant liver after living-donor liver transplantation for polycystic liver disease. | Clinical journal of gastroenterology | ||
| Relaxation Response Training to Treat Hypertension | Upregulating vascular endothelial K2.3 channels alleviates pulmonary hypertension in mice. | Molecular pharmacology | ||
| Relaxation Response Training to Treat Hypertension | Acute intravenous antihypertensive and in vitro vasorelaxant effect of the hydroalcoholic stem bark extract of Hymenaea rubriflora Ducke in spontaneously hypertensive rats. | The Journal of pharmacy and pharmacology | ||
| transcutaneous vagus nerve stimulation | Transcutaneous vagus nerve stimulation and exercise-induced autonomic regulation: a systematic review. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society | ||
| transcutaneous vagus nerve stimulation | Transcutaneous vagus nerve stimulation for postoperative pain reduction in patients with childhood trauma: A randomized controlled pilot study. | Journal of psychosomatic research | ||
| Digoxin | Sub-Saharan African Prostate Cancer Patient-Derived Cell Lines and High-Throughput Drug Screening: Addressing Ancestry Underrepresentation in Oncobiology Research. | Cancers | ||
| Digoxin | Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis. | Journal of clinical medicine | ||
| transcutaneous vagus nerve stimulation | Comparing Electrical and Ultrasound Transcutaneous Auricular Vagus Nerve Stimulation on Associative Memory. | Neuromodulation : journal of the International Neuromodulation Society | ||
| Digoxin | The Use of Cardiotonic Drugs in Neonates. | Clinics in perinatology | ||
| Digoxin | Multi-organ AI endophenotypes chart the heterogeneity of brain, eye and heart pan-disease. | Nature. Mental health | ||
| Digoxin | A varying presentation of refractory supra ventricular tachycardia in a newborn: A rare and unusual case report. | Journal of family medicine and primary care | ||
| Digoxin | BRASH Syndrome Unmasked: Digoxin Toxicity in the Setting of Cardiogenic Shock and Multiorgan Dysfunction. | Case reports in critical care | ||
| Digoxin | Ivabradine in refractory neonatal ectopic atrial tachycardia: expanding therapeutic options in early life. | Cardiology in the young | ||
| Digoxin | [Dangerous Overdose: Myocardial Injury from Digitoxin Intoxication]. | Deutsche medizinische Wochenschrift (1946) | ||
| Digoxin | Evaluating bias in target trial emulation for heart failure across statistical and deep learning methods. | Nature communications | ||
| Investigating Exercise in Myotonic Dystrophy Type 2 (DM2) | Comparison of temporal and stride characteristics in myotonic dystrophies type 1 and 2 during dual-task walking. | Gait & posture | ||
| Digoxin | Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist. | Clinical pharmacology and therapeutics | ||
| Digoxin | Comparative effectiveness of 200mcg versus 400mcg misoprostol dosing for medication abortion from 24-27 weeks' gestation. | Contraception |